eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Daiichi Sankyo UK Limited

Chiltern Place, Chalfont Park, Gerrards Cross, Buckinghamshire, SL9 0BG, UK
Telephone: +44 (0)1753 482 771
Medical Information Direct Line: +44 (0)1753 482 771
Medical Information e-mail: medinfo@daiichi-sankyo.co.uk
Customer Care direct line: +44 (0)1753 482 771
Medical Information Fax: +44 (0)1753 893 894
Out of Hours Telephone: +44 (0)1748 828 818

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 24/01/2012
PIL OLMETEC Plus 20mg/25mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 21/05/2008 and displayed until 24/01/2012
Reasons for adding or updating:
  • Transfer to upgraded management system
  • Individual presentations superseded by joint PIL
Updated on 26/09/2006 and displayed until 21/05/2008
Reasons for adding or updating:
  • Company name change or merger
Updated on 27/04/2006 and displayed until 26/09/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 26/04/2006 and displayed until 27/04/2006
Reasons for adding or updating:
  • Change to packaging
Updated on 26/04/2006 and displayed until 26/04/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   hydrochlorothiazide
   olmesartan medoxomil